About us
Biomarkers have tremendous potential to identify new drug targets, enable early disease detection, improve clinical trial success rates, and aid development of personalized medicines. Fueled by the increasing diagnostic applications of biomarkers and new initiatives for biomarker research, the biomarker market is experiencing a period of rapid growth and is already changing the way physicians diagnose and treat patients. A proven leader in the biomarker realm, BioAgilytix’s scientists have decades of combined experience providing expert biomarker discovery, development, and validation services that help organizations assess the efficacy, safety, and mechanism of action of biologics throughout the drug development process – from exploratory to regulated studies. Explore this page to gain deeper insight into our biomarker expertise, and to stay updated with the latest news and research coming from this exciting, rapidly evolving area of study.
- Website
-
http://www.BioAgilytix.com
External link for Biomarkers & Biomarker Studies
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Durham, NC
- Founded
- 2008
- Specialties
- Biomarkers, Biomarker Studies, Biomarker Assays, Biomarker Development, Biomarker Discovery, Biomarker Sample Analysis, Biomarker Validation, and Biomarker Quantification